Anesthetic Implications of G6PD Deficiency
Patients with G6PD deficiency can safely undergo general anesthesia with standard agents, but you must absolutely avoid methylene blue and minimize oxidative stressors that could trigger hemolysis or methemoglobinemia.
Key Pathophysiology
G6PD is the first enzyme in the pentose-phosphate pathway and the only source of NADPH in red blood cells. Without adequate G6PD activity, erythrocytes cannot protect themselves from oxidative stress, leading to hemolysis. Additionally, these patients cannot effectively reduce methemoglobin back to hemoglobin, making them vulnerable to methemoglobinemia 1.
Critical Drug Contraindication
Methylene blue is absolutely contraindicated in G6PD deficiency 1. While methylene blue is the standard treatment for methemoglobinemia, it paradoxically worsens methemoglobinemia and causes severe hemolysis in G6PD-deficient patients because:
- G6PD deficiency prevents adequate NADPH production needed to convert methylene blue to its active reducing form (leukomethylene blue)
- Methylene blue itself acts as an oxidant, triggering hemolysis
- If methemoglobinemia develops, use ascorbic acid (0.5-2 g IV) or exchange transfusion instead 1
Safe Anesthetic Agents
Based on recent case reports, the following agents are safe:
Induction:
Maintenance:
- Sevoflurane 2, 4
- Isoflurane 4
- Propofol infusion (avoid prolonged high-dose due to general propofol infusion syndrome risk, not G6PD-specific)
- Nitrous oxide 4
Opioids:
Muscle Relaxants:
Local Anesthetics:
- Mepivacaine (lower methemoglobinemia risk than other amides) 3
- Avoid prilocaine and benzocaine (high methemoglobinemia risk)
Perioperative Management Algorithm
Preoperative Assessment
- Document G6PD deficiency variant if known (severity varies)
- Baseline hemoglobin/hematocrit
- Screen for recent hemolytic triggers (infections, certain foods like fava beans, oxidant drugs)
- Identify family history of G6PD deficiency 1
- Ensure blood products available if major surgery
Intraoperative Management
Minimize oxidative stress:
- Use lowest FiO₂ needed to maintain SpO₂ >95% 2
- Maintain normothermia 2
- Maintain hemodynamic stability 2
- Avoid prolonged fasting - start IV dextrose-containing fluids during preoperative period 2
Monitoring considerations:
- Pulse oximetry may be unreliable if methemoglobinemia develops - creates a "saturation gap" where SpO₂ reads falsely low despite adequate PaO₂ 5
- If SpO₂ drops unexpectedly but patient appears clinically stable, obtain arterial blood gas with co-oximetry to measure actual methemoglobin level 5
- Standard ASA monitoring otherwise
Postoperative Surveillance
Monitor for at least 24 hours:
- Serial hemoglobin measurements 2
- Clinical signs of hemolysis: jaundice, dark urine, pallor 2, 6
- Vital signs and oxygen saturation
- Consider follow-up at 72 hours post-discharge 2
Common Pitfalls to Avoid
Do not assume normal pulse oximetry rules out methemoglobinemia - the saturation gap phenomenon means SpO₂ may plateau around 85% regardless of actual oxygenation 5
Do not use methylene blue even in emergency methemoglobinemia - it will worsen the condition. Use ascorbic acid or arrange urgent exchange transfusion 1
Do not use primaquine perioperatively (if treating malaria) - limit to maximum 5 days in G6PD deficiency due to life-threatening hemolysis risk 7
Do not overlook female patients - while X-linked, females can be affected and present with NIHF or severe anemia 8
Emergency Management
If hemolysis or methemoglobinemia develops:
- Stop all potential oxidant triggers
- Administer IV fluids for hydration
- For methemoglobinemia: ascorbic acid 1-2 g IV (may require multiple doses over 24 hours) 1
- Arrange urgent hematology consultation
- Prepare for exchange transfusion if severe 1
- Hyperbaric oxygen is an alternative for refractory methemoglobinemia 5
The evidence demonstrates that with appropriate drug selection and oxidative stress minimization, patients with G6PD deficiency tolerate anesthesia well, with multiple case reports showing uneventful perioperative courses 2, 6, 9, 3, 4, 5.